CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 185 filers reported holding CYTOKINETICS INC in Q4 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,028,635 | +65.9% | 102,805 | +83.7% | 0.00% | +100.0% |
| Q2 2023 | $1,825,056 | -35.0% | 55,949 | -29.8% | 0.00% | -50.0% |
| Q1 2023 | $2,805,628 | +14.1% | 79,728 | +48.6% | 0.00% | 0.0% |
| Q4 2022 | $2,459,159 | -100.0% | 53,670 | -48.5% | 0.00% | -50.0% |
| Q3 2022 | $5,048,684,000 | +111.4% | 104,204 | +71.4% | 0.01% | +100.0% |
| Q2 2022 | $2,388,478,000 | -8.7% | 60,791 | -14.5% | 0.00% | 0.0% |
| Q1 2022 | $2,616,639,000 | -69.9% | 71,085 | -62.7% | 0.00% | -66.7% |
| Q4 2021 | $8,693,929,000 | +179.4% | 190,740 | +119.1% | 0.01% | +200.0% |
| Q3 2021 | $3,111,346,000 | +367.0% | 87,055 | +158.6% | 0.00% | +300.0% |
| Q2 2021 | $666,250,000 | +43.2% | 33,666 | +68.3% | 0.00% | 0.0% |
| Q1 2021 | $465,363,000 | +135.3% | 20,007 | +110.2% | 0.00% | – |
| Q4 2020 | $197,805,000 | -45.8% | 9,519 | -43.5% | 0.00% | -100.0% |
| Q3 2020 | $364,673,000 | +140.5% | 16,844 | +161.8% | 0.00% | – |
| Q2 2020 | $151,649,000 | -93.8% | 6,434 | -96.9% | 0.00% | -100.0% |
| Q1 2020 | $2,460,408,000 | +1704.8% | 208,686 | +1524.1% | 0.01% | – |
| Q4 2019 | $136,328,000 | +54.4% | 12,849 | +65.6% | 0.00% | – |
| Q3 2019 | $88,275,000 | +53.6% | 7,757 | +51.9% | 0.00% | – |
| Q2 2019 | $57,454,000 | -25.8% | 5,107 | -46.6% | 0.00% | – |
| Q1 2019 | $77,429,000 | +76562.4% | 9,571 | +59718.8% | 0.00% | – |
| Q4 2018 | $101,000 | -99.3% | 16 | -99.0% | 0.00% | – |
| Q3 2018 | $15,130,000 | +18.7% | 1,536 | 0.0% | 0.00% | – |
| Q2 2018 | $12,749,000 | -87.9% | 1,536 | -89.5% | 0.00% | – |
| Q1 2018 | $105,019,000 | -33.3% | 14,586 | -24.5% | 0.00% | – |
| Q4 2017 | $157,401,000 | -56.3% | 19,313 | -22.2% | 0.00% | -100.0% |
| Q3 2017 | $359,818,000 | +123.1% | 24,815 | +86.2% | 0.00% | – |
| Q2 2017 | $161,269,000 | +4198.2% | 13,328 | +4464.4% | 0.00% | – |
| Q1 2017 | $3,752,000 | -83.8% | 292 | -84.7% | 0.00% | – |
| Q4 2016 | $23,146,000 | +10.5% | 1,905 | -16.5% | 0.00% | – |
| Q3 2016 | $20,940,000 | +67.5% | 2,281 | +73.2% | 0.00% | – |
| Q2 2016 | $12,498,000 | -82.2% | 1,317 | -80.3% | 0.00% | – |
| Q4 2015 | $70,040,000 | +24.8% | 6,696 | -20.2% | 0.00% | – |
| Q3 2015 | $56,129,000 | +189.4% | 8,390 | +190.7% | 0.00% | – |
| Q2 2015 | $19,394,000 | +248.8% | 2,886 | +252.0% | 0.00% | – |
| Q1 2015 | $5,560,000 | -25.3% | 820 | -61.2% | 0.00% | – |
| Q3 2014 | $7,448,000 | +2097.1% | 2,116 | +2880.3% | 0.00% | – |
| Q2 2014 | $339,000 | +294.2% | 71 | +273.7% | 0.00% | – |
| Q1 2014 | $86,000 | -96.2% | 19 | -94.5% | 0.00% | – |
| Q4 2013 | $2,243,000 | – | 345 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |